Sphera Funds Management Ltd. Zymeworks Inc. Transaction History

Sphera Funds Management Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $7.31 Million - $13.9 Million	-245,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.12 - $54.99 $6.45 Million - $9.07 Million	165,000 Added 206.25%	245,000 $11.6 Million
Q3 2020 Nov 12, 2020	SELL	$29.21 - $46.58 $1.06 Million - $1.69 Million	-36,310 Reduced 31.22%	80,000 $3.73 Million
Q2 2020 Aug 13, 2020	SELL	$33.67 - $40.0 $3.05 Million - $3.62 Million	-90,520 Reduced 43.77%	116,310 $4.2 Million
Q1 2020 May 14, 2020	BUY	$24.28 - $49.8 $1.21 Million - $2.48 Million	49,830 Added 31.74%	206,830 $7.34 Million
Q4 2019 Feb 13, 2020	SELL	$24.84 - $45.46 $322,920 - $590,980	-13,000 Reduced 7.65%	157,000 $7.14 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $29.08 $3.87 Million - $4.94 Million	170,000 New	170,000 $4.22 Million
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $808,110 - $1.14 Million	-73,800 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$11.13 - $21.86 $821,394 - $1.61 Million	73,800 New	73,800 $1.09 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.